FDA Adverse Event Injury Summary report: N

GORE® EXCLUDER® AAA ENDOPROSTHESIS

MDR report key: 4213156 · Received October 30, 2014

Report

Report Number
2017233-2014-00562
Event Type
Injury
Date Received
October 30, 2014
Date of Event
November 20, 2013
Report Date
November 7, 2014
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

W.L. GORE & ASSOCIATES, INC. (GORE) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Additional Manufacturer Narrative · 1

PLEASE NOTE, ADDITIONAL DEVICES IMPLANTED IN THIS PATIENT AND INVOLVED IN THIS EVENT INCLUDE: PLC181000 LOT # 11441813, PLC231400 LOT # 11535877.

Description of Event or Problem · 1

ON (B)(6) 2013 A PATIENT IN THE (B)(6) STUDY WAS IMPLANTED WITH A GORE® EXCLUDER® AAA ENDOPROSTHESIS FEATURING C3® DELIVERY SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT WAS DISCHARGED AT (B)(6) 2013. ON (B)(6) 2013 THE PATIENT PRESENTED WITH A BILATERAL TYPE I ENDOLEAK DISTAL. ON (B)(6) 2013 THE PATIENT WAS IMPLANTED WITH 2 GORE® EXCLUDER® AAA ENDOPROSTHESIS COMPONENTS IN THE LEFT LEG TO AND 2 GORE® VIABAHN® ENDOPROSTHESIS IN THE RIGHT LEG TO TREAT THE BILATERAL TYPE I ENDOLEAK DISTAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
697314 GORE® EXCLUDER® AAA ENDOPROSTHESIS SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES 11488223

Patients

Seq Age Sex Outcome Treatment
1 79 YR Hospitalization| R